Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals
On November 3, 2025, Florin Court Capital LLP disclosed a new position in iShares Biotechnology ETF (IBB), acquiring 77,000 shares in a trade valued at approximately $11.1 million. The transaction represents 8.7% of the firm’s 13F reportable assets under management (AUM). Post-trade position: 77,00…